5-Hydroxytryptamine Receptor 5A (HTR5A) Gene
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">HTR5A Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>HTR5A</td>
</tr>
<tr>
<td class="label">Official Full Name</td>
<td>5-hydroxytryptamine receptor 5A</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>7q36.3</td>
</tr>
<tr>
<td class="label">Gene ID</td>
<td>3363</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P30939</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>G protein-coupled receptor, Family 5-HT</td>
</tr>
<tr>
<td class="label">Drug Class</td>
<td>Examples</td>
</tr>
<tr>
<td class="label">Agonists</td>
<td>LSD, 5-CT</td>
</tr>
<tr>
<td class="label">Antagonists</td>
<td>SB-699929, AS-203</td>
</tr>
<tr>
<td class="label">Mixed agents</td>
<td>Various atypical antipsychotics</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Overview
HTR5A is a human gene. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.
The HTR5A gene encodes the 5-hydroxytryptamine receptor 5A (also known as 5-HT5A), a G protein-coupled receptor (GPCR) that binds serotonin (5-hydroxytryptamine or 5-HT) as its endogenous ligand. The 5-HT5A receptor is one of the least characterized serotonin receptor subtypes, yet it plays important roles in neural development, sleep architecture, and cognitive processes.
Gene Overview
Protein Structure and Function
The 5-HT5A receptor is a seven-transmembrane domain GPCR that couples primarily to Gα<sub>i/o</sub> proteins, leading to inhibition of adenylate cyclase and reduced cyclic AMP (cAMP) production. This receptor is expressed predominantly in the central nervous system (CNS), with highest expression in the cerebral cortex, hippocampus, hypothalamus, and raphe nuclei.
Signaling Pathways
Upon serotonin binding, 5-HT5A receptor activation triggers the following intracellular signaling cascades:
cAMP Pathway: Inhibition of adenylate cyclase reduces cAMP levels, modulating protein kinase A (PKA) activity
MAPK Pathway: Activation of extracellular signal-regulated kinases (ERK1/2) in certain neuronal populations
PI3K/Akt Pathway: Modulation of neuronal survival signaling
Ion Channel Modulation: Regulation of potassium channel activity through βγ subunitsExpression Pattern
In the brain, 5-HT5A receptors are localized to:
- Cerebral cortex: Particularly layer V pyramidal neurons
- Hippocampus: CA1 and CA3 regions, dentate gyrus
- Hypothalamus: Preoptic area and suprachiasmatic nucleus
- Raphe nuclei: serotonergic neuron cell bodies
- Cerebellum: Purkinje cells and granular layer
This distribution suggests roles in mood regulation, memory consolidation, circadian rhythm control, and motor coordination.
Biological Roles
Sleep Regulation
The 5-HT5A receptor plays a critical role in sleep-wake cycling. Studies in knockout mice demonstrate that HTR5A deletion results in:
- Increased rapid eye movement (REM) sleep duration
- Altered non-REM sleep architecture
- Disrupted circadian sleep patterns
The receptor's expression in the suprachiasmatic nucleus links it to circadian rhythm regulation.
Cognitive Function
Evidence from animal models suggests involvement in:
- Learning and memory formation
- Synaptic plasticity
- Hippocampal long-term potentiation (LTP)
5-HT5A antagonists have been shown to enhance certain forms of memory in preclinical studies.
Mood and Behavior
While less studied than other serotonin receptors (5-HT1A, 5-HT2A), the 5-HT5A receptor is implicated in:
- Anxiety-related behaviors
- Depression pathophysiology
- Schizophrenia (potential antipsychotic target)
Clinical Significance
Neurodegenerative Diseases
Although not a primary disease-causing gene, HTR5A variations may modify disease progression in:
Alzheimer's Disease (AD):
- 5-HT5A receptor density is altered in AD brains
- Receptor signaling may interact with amyloid-β pathology
- Potential therapeutic target for cognitive symptoms
Parkinson's Disease (PD):
- Altered serotonergic receptor expression in PD brains
- 5-HT5A modulators may help levodopa-induced dyskinesias
Psychiatric Disorders
Schizophrenia:
- Postmortem studies show altered 5-HT5A binding in schizophrenia brains
- Atypical antipsychotics may act as 5-HT5A antagonists
- Clinical trials of 5-HT5A antagonists are ongoing
Major Depressive Disorder:
- Some antidepressant effects may involve 5-HT5A modulation
- Interaction with SSRIs and SNRIs
Epilepsy
The 5-HT5A receptor has been implicated in seizure susceptibility. Animal studies show that 5-HT5A agonists have anticonvulsant properties, while antagonists may lower seizure thresholds.
Pharmacological Targets
Drug Development
Pharmaceutical companies have shown interest in 5-HT5A ligands for:
- Cognitive enhancement in dementia
- Treatment-resistant depression
- Schizophrenia (adjunct therapy)
- Sleep disorders
Genetics and Variants
Known Polymorphisms
Several single nucleotide polymorphisms (SNPs) in HTR5A have been studied:
- rs6293: Promoter variant potentially affecting expression
- rs6294: Coding variant with unknown functional significance
- rs1800042: Associated with psychiatric phenotypes in some studies
Association Studies
Genetic association studies have linked HTR5A variants to:
- Schizophrenia susceptibility (mixed results)
- Bipolar disorder
- Migraine frequency
- Sleep duration
Interactions and Network
The 5-HT5A receptor interacts with:
Protein Partners:
- G-proteins (Gα<sub>i/o</sub> family)
- β-arrestin 2
- RGS proteins (regulators of G protein signaling)
- PSD-95 (in neurons)
Cross-talk Pathways:
- Dopamine D2 receptor signaling
- GABA<sub>A</sub> receptor modulation
- Glutamate receptor activity (NMDA, AMPA)
Animal Models
- HTR5A knockout mice: Viable with sleep and behavioral alterations
- Conditional knockouts: Brain-specific deletions
- Transgenic reporters: For receptor visualization
Antibodies and Ligands
- Radioligands: [³H]5-CT, [¹²⁵I]LSD
- Antibodies: Commercial antibodies for Western blot, IHC
- Fluorescent ligands: For live-cell imaging
Summary
The HTR5A gene encodes an important but understudied serotonin receptor with roles in sleep regulation, cognitive function, and mood. While not a primary driver of neurodegeneration, understanding 5-HT5A function may reveal:
- Novel therapeutic targets for cognitive disorders
- Mechanisms of serotonergic signaling in the brain
- Interactions between neurotransmitter systems in disease
Further research is needed to fully characterize this receptor's functions and therapeutic potential.
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [NCBI Gene: HTR5A](https://www.ncbi.nlm.nih.gov/gene/?term=HTR5A)
- [GeneCards: HTR5A](https://www.genecards.org/cgi-bin/carddisp.pl?gene=HTR5A)
- [OMIM: HTR5A](https://omim.org/search?search=HTR5A)
- [Ensembl: HTR5A](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=HTR5A)
- [Allen Brain Atlas: HTR5A](https://human.brain-map.org/microarray/search/show?search_term=HTR5A)
References
Unknown, HTR5A gene (official symbol) (n.d.)
Unknown, 5-HT5A receptor signaling pathways (n.d.)
Unknown, Serotonin receptor classification (n.d.)
[Unknown, HTR5A knockout mouse phenotype (n.d.)](https://pubmed.ncbi.nlm.nih.gov/10625787/)
[Unknown, 5-HT5A and sleep regulation (n.d.)](https://pubmed.ncbi.nlm.nih.gov/10874591/)
[Unknown, Antipsychotic binding to 5-HT5A (n.d.)](https://pubmed.ncbi.nlm.nih.gov/15728830/)
[Unknown, Cognitive effects of 5-HT5A modulation (n.d.)](https://pubmed.ncbi.nlm.nih.gov/14687658/)
[Unknown, 5-HT5A in Alzheimer's disease (n.d.)](https://pubmed.ncbi.nlm.nih.gov/23415642/)